Current and future biomarkers in allergic asthma

UM Zissler, J Esser‐von Bieren, CA Jakwerth… - Allergy, 2016 - Wiley Online Library
Diagnosis early in life, sensitization, asthma endotypes, monitoring of disease and treatment
progression are key motivations for the exploration of biomarkers for allergic rhinitis and …

Anti-interleukin 5 (IL-5) and IL-5Ra biological drugs: efficacy, safety, and future perspectives in severe eosinophilic asthma

D Bagnasco, M Ferrando, G Varricchi… - Frontiers in …, 2017 - frontiersin.org
The definition of asthma has changed considerably in recent years, to the extent that asthma
is no longer considered a single disease but a heterogeneous disorder that includes several …

Prognostic biomarkers based on proteomic technology in COPD: a recent review

H Fang, Y Liu, Q Yang, S Han… - International Journal of …, 2023 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a common heterogeneous respiratory
disease which is characterized by persistent and incompletely reversible airflow limitation …

Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

AM Riccio, P Mauri, L De Ferrari, R Rossi… - Clinical and translational …, 2017 - Springer
Background Bronchial asthma is a heterogeneous disease characterized by three cardinal
features: chronic inflammation, variable airflow obstruction, and airway …

iTRAQ‐based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

JJ Nieto‐Fontarigo, FJ González‐Barcala… - Allergy, 2020 - Wiley Online Library
Background Asthma is heterogeneous disease with different phenotypes, endotypes and
severities. Definition of these subgroups requires the identification of biomarkers in …

Targeted therapy in severe asthma today: focus on immunoglobulin E

G Pelaia, GW Canonica, A Matucci… - Drug design …, 2017 - Taylor & Francis
Asthma is a complex chronic inflammatory disease of multifactorial etiology. International
guidelines increasingly recognize that a standard “one size fits all” approach is no longer an …

Inflammatory biomarkers for asthma endotyping and consequent personalized therapy

G Ciprandi, MA Tosca, M Silvestri… - Expert Review of …, 2017 - Taylor & Francis
Introduction: We argue that asthma be considered a syndrome caused by multiple
inflammatory pathogenic processes. Bronchial hyperresponsiveness, reversible airflow …

Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges

HHF Tang, PD Sly, PG Holt, KE Holt… - European Respiratory …, 2020 - Eur Respiratory Soc
Asthma is a common condition caused by immune and respiratory dysfunction, and it is often
linked to allergy. A systems perspective may prove helpful in unravelling the complexity of …

Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma

K Fujii, H Nakamura, T Nishimura - Expert Review of Proteomics, 2017 - Taylor & Francis
Introduction: Lung cancer and related diseases have been one of the most common causes
of deaths worldwide. Genomic-based biomarkers may hardly reflect the underlying dynamic …

Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?

L De Ferrari, A Chiappori, D Bagnasco… - Expert review of …, 2016 - Taylor & Francis
Although different phenotypes of severe asthma can be identified, all are characterized by
common symptoms. Due to their heterogeneity, they exhibit differences in pathogenesis …